Synageva BioPharma Corp. (GEVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Synageva BioPharma Corp. (GEVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Synageva BioPharma Corp. (GEVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Synageva BioPharma Corp. (GEVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
34 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Synageva BioPharma Corp. (Synageva), formerly known as AviGenics, Inc., is a biopharmaceutical company that focuses on discovering, developing and delivering medicines. It offers its products for patients with rare disease and unmet medical needs. The companys pipeline products include Kanuma and other products in the therapeutic areas of lysosomal acid lipase deficiency (LAL D), generalized arterial calcification of infancy (GACI) and MPS IIIB, among others. Synagevas SBC-103 is a recombinant form of the human alpha-N-acetyl-glucosaminidase enzyme, which is used as an enzyme replacement therapy for mucopolysaccharidosis.

Synageva BioPharma Corp. (GEVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on maj

  
Source:
Document ID
GDPH137372D
Country
Industry
Ticker
GEVA=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Synageva BioPharma Corp., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Synageva BioPharma Corp., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Synageva BioPharma Corp., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Synageva BioPharma Corp., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Synageva BioPharma Corp., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Synageva BioPharma Corp., Pharmaceuticals &Healthcare, Deal Details1021
  Venture Financing101
    Synageva Biopharma Secures US$25 Million In Equity Financing102
  Partnerships121
    Phaserx Terminates Agreement with Synageva BioPharma121
    Synageva BioPharma Extends Co-Development Agreement With Mitsubishi Tanabe Pharma131
    Synageva BioPharma Enters Into Research Agreement With Mitsubishi Tanabe Pharma141
  Merger151
    Synageva BioPharma Completes Merger With Trimeris152
  Equity Offering171
    Synageva BioPharma Prices Public Offering of Shares for USD283 Million172
    Synageva BioPharma Completes Public Offering Of Shares For US$211.5 Million192
    Synageva BioPharma Completes Public Offering Of Shares For US$179 Million212
    Synageva BioPharma Completes Public Offering Of Common Stock For US$118 Million232
    Synageva BioPharma Completes Public Offering Of Common Stock For US$115 Million252
    Synageva BioPharma Completes Public Offering Of Common Stock For US$90 Million272
  Acquisition291
    Alexion Pharma Acquires Synageva BioPharma for USD8.4 Billion292
Synageva BioPharma Corp. - Key Competitors311
Key Employees321
Locations And Subsidiaries331
  Head Office331
  Other Locations &Subsidiaries331
Appendix341
  Methodology341
  About GlobalData341
  Contact Us341
  Disclaimer341

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Synageva BioPharma Corp. (GEVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Synageva-BioPharma-Corp-GEVA-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7256>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Synageva BioPharma Corp. (GEVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Synageva-BioPharma-Corp-GEVA-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7256>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research